Sixteen lots of clonazepam orally disintegrating tablets have been recalled because of a packaging error that could have life ...

A popular anxiety drug is being recalled over a ‘life-threatening’ label mistake. In a recall alert for certain lots of ...

Endo USA, Inc., affiliated to generics and specialty branded pharmaceutical company Endo, Inc., has expanded its recall of Clonazepam ...

The company is worried mislabeling could lead to unintentionally taking higher doses and adverse side effects.

has expanded its recall of Clonazepam Orally Disintegrating Tablets (C-IV), according to the U.S. Food and Drug Administration. The recalled drugs were mislabeled with the incorrect strength on ...

is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to potential product carton strength mislabeling. Specifically, Endo's ...

Endo USA is expanding its previous recall of orally disintegrating clonazepam tablets to include more than a dozen additional product lots, the company said in a notice posted on the FDA’s ...

(OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, USP ...

Endo USA, Inc. is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to potential product carton strength mislabeling.